Migraine device studied for safety in pregnancy
NCT ID NCT05464069
First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 33 times
Summary
This study checked if using Nerivio, a device for migraine, is safe during pregnancy and for 3 months after giving birth. It compared 145 women with migraine who used Nerivio during pregnancy to those who did not. The researchers looked at baby's birth weight, delivery timing, and miscarriage rates to see if there were any differences.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Theranica USA
Montclair, New Jersey, 07042, United States
-
University of California San Diego (UCSD)
San Diego, California, 92037, United States
Conditions
Explore the condition pages connected to this study.